Emerging roles of microRNA-22 in human disease and normal physiology

Current Molecular Medicine

Volumn 12, Issue 3, 2012, Pages 247-258

  Xiong, J ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Cancer; Embryonic stem cell; MicroRNA; MiR 22; Skeletal metabolism; Tumor suppressor

Indexed keywords

CURCUMIN; CYCLIN DEPENDENT KINASE 6; DICER; ESTROGEN RECEPTOR ALPHA; HISTONE DEACETYLASE 4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAX PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 22; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; SIRTUIN 1; TRICHOSTATIN A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE METABOLISM; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MAPPING; GENE TARGETING; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HELA CELL; HETEROZYGOSITY LOSS; HUMAN; LIVER CELL CARCINOMA; NEOPLASM; NONHUMAN; NORTHERN BLOTTING; ONCOGENE; PANIC; PATHOLOGY; PHYSIOLOGY; PREVENTIVE MEDICINE; PROGNOSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

EMBRYONIC STEM CELLS; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84857127764     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652412799218886     Document Type: Article

References (94)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-297.
2. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5(7): 522-531.
3. Lu M, Zhang Q, Deng M, et al. An analysis of human microRNA and disease associations. PLoS One 2008; 3(10): e3420.
4. Berezikov E, Cuppen E, Plasterk RH. Approaches to microRNA discovery. Nat Genet 2006; 38 Suppl: S2-7.
5. Rajewsky N. microRNA target predictions in animals. Nat Genet 2006; 38 Suppl: S8-13.
6. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36(Database issue): D154-158.
7. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294(5543): 853-858.
8. Neely LA, Patel S, Garver J, et al. A single-molecule method for the quantitation of microRNA gene expression. Nat Methods 2006; 3(1): 41-46.
9. Yamakuchi M, Yagi S, Ito T, Lowenstein CJ. MicroRNA-22 regulates hypoxia signaling in colon cancer cells. PLoS ONE 2011; 6 (5): e20251.
10. Kern SE, Fearon ER, Tersmette KW, et al. Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA 1989; 261(21): 3099-3103.
11. Cogen PH, McDonald JD. Tumor suppressor genes and medulloblastoma. J Neurooncol 1996; 29(1): 103-112.
12. Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB, Gabrielson E. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene 1998; 16(16): 2159-2164.
13. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci US A 2004; 101(9): 2999-3004.
14. Zhao X, He M, Wan D, et al. The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett 2003; 190(2): 221-232.
15. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12(9): 735-739.
16. Suzuki T, Shen H, Akagi K, et al. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002; 32(1): 166-174.
17. Wales MM, Biel MA, El Deiry W, et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1995; 1(6): 570-577.
18. Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ, Godwin AK. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 1996; 56(9): 1997-2002.
19. Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG. Expression and genetic analysis of XIAPassociated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70(1): 113-122.
20. Zhao X, Li J, He Y, et al. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res 2001; 61(20): 7383-7387.
21. Paulding CA, Ruvolo M, Haber DA. The Tre2 (USP6) oncogene is a hominoid-specific gene. Proc Natl Acad Sci USA 2003; 100(5): 2507-2511.
22. Di Marcotullio L, Ferretti E, De Smaele E, et al. REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma. Proc Natl Acad Sci USA 2004; 101(29): 10833-10838.
23. Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer 2009; 9(10): 749-758.
24. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10(12): 1957-1966.
25. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14(10A): 1902-1910.
26. Bar N, Dikstein R. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS One 2010; 5(5): e10859.
27. Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 2002; 71: 817-846.
28. Farajollahi S, Maas S. Molecular diversity through RNA editing: a balancing act. Trends Genet 2010; 26(5): 221-230.
29. Das AK, Carmichael GG. ADAR editing wobbles the microRNA world. ACS Chem Biol 2007; 2(4): 217-220.
30. Luciano DJ, Mirsky H, Vendetti NJ, Maas S. RNA editing of a miRNA precursor. RNA 2004; 10(8): 1174-1177.
31. Stark MS, Tyagi S, Nancarrow DJ, et al. Characterization of the melanoma miRNAome by deep sequencing. PLoS One 2010; 5(3): e9685.
32. Bar M, Wyman SK, Fritz BR, et al. MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Stem Cells 2008; 26(10): 2496-2505.
33. Xie X, Lu J, Kulbokas EJ, et al. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 2005; 434(7031): 338-345.
34. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 2008; 7(3): 464-473.
35. Leivonen SK, Makela R, Ostling P, et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009; 28(44): 3926-3936.
36. Pandey DP, Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 2009; 29(13): 3783-3790.
37. Xiong J, Yu D, Wei N, et al. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 2010; 277(7): 1684-1694.
38. Zhang J, Yang Y, Yang T, et al. microRNA-22, downregulated in hepatocellular carcinoma and correlatedwith prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010; 103(8): 1215-1220.
39. Xu D, Takeshita F, Hino Y, et al. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 2011; 193(2): 409-424.
40. Tsuchiya N, Izumiya M, Ogata-Kawata H, et al. Tumorsuppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res 2011; 71: 4628.
41. Xiong J, Du Q, Liang Z. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 2010; 29 (35): 4980-4988.
42. Ting Y, Medina DJ, Strair RK, Schaar DG. Differentiationassociated miR-22 represses Max expression and inhibits cell cycle progression. Biochem Biophys Res Commun 2010; 394(3): 606-611.
43. El Baroudi M, Cora D, Bosia C, Osella M, Caselle M. A curated database of miRNA mediated feed-forward loops involving MYC as master regulator. PLoS One 2011; 6(3): e14742.
44. Li X, Liu J, Zhou R, Huang S, Chen XM. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. Br J Haematol 2010; 148(1): 69-79.
45. Nagaraja AK, Creighton CJ, Yu Z, et al. A link between mir- 100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 2010; 24(2): 447-463.
46. Patel JB, Appaiah HN, Burnett RM, et al. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene 2011; 30(11): 1290-1301.
47. Li J, Liang S, Yu H, Zhang J, Ma D, Lu X. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol 2010; 119 (3): 543-548.
48. Li J, Liang SH, Lu X. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis]. Zhonghua Fu Chan Ke Za Zhi 2010; 45(10): 787-792.
49. Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008; 105(10): 3945-3950.
50. Kawahigashi Y, Mishima T, Mizuguchi Y, et al. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J Nippon Med Sch 2009; 76(4): 188-197.
51. Melo SA, Ropero S, Moutinho C, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41(3): 365-370.
52. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006; 116(3): 561-570.
53. Cole MD, McMahon SB. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 1999; 18(19): 2916-2924.
54. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18(19): 3004-3016.
55. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. Analysis of genomic targets reveals complex functions of MYC. Nat Rev Cancer 2004; 4(7): 562-568.
56. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435(7043): 828-833.
57. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435(7043): 839-843.
58. Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 2006; 38(9): 1060-1065.
59. Chang TC, Yu D, Lee YS, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40(1): 43-50.
60. Sander S, Bullinger L, Klapproth K, et al. MYC stimulates EZH2 expression by repression of its negative regulator miR- 26a. Blood 2008; 112(10): 4202-4212.
61. Mestdagh P, Fredlund E, Pattyn F, et al. MYCN/c-MYCinduced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene 2009; 29(9): 1394-1404.
62. Gao P, Tchernyshyov I, Chang TC, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458(7239): 762-765.
63. Lin CH, Jackson AL, Guo J, Linsley PS, Eisenman RN. Mycregulated microRNAs attenuate embryonic stem cell differentiation. EMBO J 2009; 28(20): 3157-3170.
64. Taira T, Maeda J, Onishi T, et al. AMY-1, a novel C-MYC binding protein that stimulates transcription activity of CMYC. Genes Cells 1998; 3(8): 549-565.
65. Sakamuro D, Prendergast GC. New Myc-interacting proteins: a second Myc network emerges. Oncogene 1999; 18(19): 2942-2954.
66. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96(8): 4240-4245.
67. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000; 100(4): 387-390.
68. Liu L, Jiang Y, Zhang H, Greenlee AR, Yu R, Yang Q. miR- 22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8- diol-9,10-epoxide. Toxicol In Vitro 2010; 24(4): 1168-1175.
69. Poliseno L, Salmena L, Riccardi L, et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTENtargeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010; 3(117): ra29.
70. Li J, Zhang Y, Zhao J, Kong F, Chen Y. Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Mol Cell Biochem2011; 357 (1/2): 31-38.
71. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6(4): 259-269.
72. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cellspecific MicroRNAs. Dev Cell 2003; 5(2): 351-358.
73. Ibarra I, Erlich Y, Muthuswamy SK, Sach idanandam R, Hannon GJ. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 2007; 21(24): 3238-3243.
74. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008; 3(11): e3740.
75. Muinos-Gimeno M, Espinosa-Parrilla Y, Guidi M, et al. Human microRNAs miR-22, miR-138-2, miR-148a, and miR- 488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry 2011; 69(6): 526-533.
76. Xu XD, Song XW, Li Q, Wang GK, Jing Q, Qin YW. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy. J Cell Physiol 2011 (Epub ahead of print).
77. Cobb BS, Hertweck A, Smith J, et al. A role for Dicer in immune regulation. J Exp Med 2006; 203(11): 2519-2527.
78. Choong ML, Yang HH, McNiece I. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp Hematol 2007; 35(4): 551-564.
79. Caruso P, MacLean MR, Khanin R, et al. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 2010; 30(4): 716-723.
80. Eisenberg I, Eran A, Nishino I, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 2007; 104(43): 17016-17021.
81. Torley KJ, da Silveira JC, Smith P, et al. Expression of miRNAs in ovine fetal gonads: potential role in gonadal differentiation. Reprod Biol Endocrinol 2011; 9: 2.
82. Jian P, Li ZW, Fang TY, et al. Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol 2011; 4(1): 20.
83. Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP. Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer 2011; 10(1): 58.
84. Zheng ZF, Su HF, Zou Y, Peng Z, Wu SX. Expression profiles of microRNAs in radioresistant esophageal cell line. Zhonghua Yi Xue Za Zhi 2011; 91(9): 639-642.
85. Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122(6): 947-956.
86. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6(11): 857-866.
87. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433(7027): 769-773.
88. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37(5): 495-500.
89. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455(7209): 64-71.
90. Castanotto D, Rossi JJ. The promises and pitfalls of RNAinterference-based therapeutics. Nature 2009; 457(7228): 426-433.
91. Robertson B, Dalby AB, Karpilow J, Khvorova A, Leake D, Vermeulen A. Specificity and functionality of microRNA inhibitors. Silence 2010; 1(1): 10.
92. Zhang C, Wang C, Chen X, et al. Expression profile of MicroRNAs in serum: A fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010; 56 (12): 1871-1879.
93. Zhu HT, Dong QZ, Wang G, et al. Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol 2011 (Epub ahead of print).
94. Margis R, Rieder CR. Identification of blood microRNAs associated to Parkinsons disease. J Biotechnol 2011 Mar 20; 152(3): 96-101.